Cotización ProShares Ultra Dow30 - DDM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

97.15

Postura de Compra

Postura de Venta

Volume Operado de la Acción

543,179

94.05 Rango del Día 98.64

76.58 Rango de 52 semanas 107.60

Capitalización de Mercado [m]

456.605M

Precio Anterior

94.78

Precio de Apertura

94.16

Hora

1596

97.06

Última hora de negociación

Volumen financiero

US$ 52,612,805

Precio Promedio Ponderado

96.8609

Volumen promedio (3 m)

276,109

Acciones en circulación

4,700,000

Rendimiento del Dividendo

Ratio Precio/Utilidad

4.48

Beneficio por acción (BPA)

21.68

turnover

8.44M

Beneficio neto

101.88M

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones Industrial Average Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consiste... The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones Industrial Average Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment objective. The index is a price-weighted index and includes 30 large-cap, blue-chip U.S. stocks, excluding utility and transportation companies. The fund is non-diversified. Mostrar más

Sector

Mgmt Invt Offices, Open-end

Industria

Mgmt Invt Offices, Open-end

Sitio web

www.proshares.com

Sede

Bethesda, Maryland, USA

Fundado

ProShares Ultra Dow30 is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker DDM. The last closing price for ProShares Ultra Dow30 was US$94.78. Over the last year, ProShares Ultra Dow30 shares have traded in a share price range of US$ 76.58 to US$ 107.60.

ProShares Ultra Dow30 currently has 4,700,000 shares in issue. The market capitalisation of ProShares Ultra Dow30 is US$445.47 million. ProShares Ultra Dow30 has a price to earnings ratio (PE ratio) of 4.48.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-5.22	-5.09915014164	102.37	102.65	94.56	337876	97.25528027	SP
4	-5.05	-4.94129158513	102.2	107.6	94.56	237472	102.32327233	SP
12	1.74	1.82370820669	95.41	107.6	92.1001	276109	99.1079634	SP
26	15.12	18.4322808729	82.03	107.6	79.78	263821	93.30574301	SP
52	18.73	23.8842132109	78.42	107.6	76.58	276120	87.36606429	SP
156	23.01	31.0358780685	74.14	107.6	48.42	389600	70.52508538	SP
260	41.39	74.2288378766	55.76	107.6	21	498411	59.06699924	SP

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.32M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	305.1M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	292.16M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	287.21M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	277.63M